38results about How to "The composition is less" patented technology

Hemostatic agents and devices are made from oxidized cellulose fiber, the oxidized cellulose having a carboxylation content increased by the action of nitrogen dioxide on virgin cellulose fiber. A composition may be incorporated into the oxidized cellulose fiber to cause a pharmacological effect on a wound to which the hemostatic agents and devices are applied. When applied, the oxidized cellulose fiber causes blood emanating from the wound to clot. The oxidized cellulose fiber can either be resorbed into the wound or removed from the wound after healing. A hemostatic bandage includes a pad of unwoven oxidized cellulose fibers mounted on a substrate. Methods of arresting a flow of blood emanating from a wound using such devices are also disclosed. Methods of fabricating oxidized cellulose are also disclosed.

An apparatus for modifying a keratinous surface having an applicator, a first modification agent; a sensor; and a CPU. The sensor reads the properties of a small portion of the keratinous surface, the readings are transmitted to the CPU, and the CPU compares the readings to a predetermined baseline value. The CPU then calculates the variance between the reading and the baseline value. When that variance exceeds a predetermined threshold the CPU sends a signal to the applicator which is activated to apply a portion of the first modification composition to the same portion of the keratinous surface that had the reading with a variance above the threshold value.

An apparatus for modifying a keratinous surface that has a rotatable applicator that is in fluid communication with a first modification composition. The apparatus also has a sensor and a CPU. The sensor is positioned forward of the applicator head such that as the head rolls across the keratinous surface the sensor reads the portion of the keratinous surface in front of the rolling head. The sensor readings are transmitted to the CPU, the CPU analyzes the sensor readings of the keratinous surface, and the CPU sends a signal to the applicator head to treat or not to treat the analyzed surface. When the CPU sends a signal to the applicator to treat the surface, a small portion of the first modification composition is applied to the head such that when the head rolls over the keratinous surface the first modification composition contacts the area of the keratinous surface that needs treatment.

An apparatus for modifying a keratinous surface that has an applicator that with a motor, and at least one protrusion The applicator further has a ribbon with a first and second side, the first side being adjacent the protrusion and a first modification composition on the second side of the ribbon. Further there is a sensor and a CPU. The sensor reads the properties of a small portion of the keratinous surface, the readings are transmitted to the CPU. If the CPU sends a signal to the applicator to treat the surface, the motor is activated to move the applicator to the keratinous surface such that the ribbon contacts the keratinous surface near the protrusion to apply a portion of the first modification composition to the keratinous surface that was read by the sensor.

The invention discloses synergistic combinations of surfactants blends and cleaning composition. In certain embodiments a surfactant system is disclosed which includes extended anionic surfactants, linker surfactants, and a multiply charged cation component. This system forms emulsions with, and can remove greasy and oily stains, even those comprised of non-trans fats. In another embodiment anionic surfactants are combined with a solvent, and amine oxide to remove sunscreen stains. The compositions may be used alone, as a pre-spotter or other pre-treatment or as a part of a soft surface or hard surface cleaning composition.

Disclosed are hydrophobic finish compositions and cementitious articles made with the hydrophobic finish compositions. In some embodiments, the article is a waterproof gypsum panel surface reinforced with inorganic mineral fibers that face a flexible and hydrophobic cementitious finish possessing beneficial waterproofing properties. These waterproof gypsum panels have many uses, such as, tile backer board in wet or dry areas of buildings, exterior weather barrier panel for use as exterior sheathing, interior wall and ceiling, and roof cover board having water durability and low surface absorption. The flexible and hydrophobic cementitious finish can include fly ash, film-forming polymer, preferably silane compound (e.g., alkyl alkoxysilane), an extended flow time retention agent including either one or more carboxylic acids, salts of carboxylic acids, or mixtures thereof, and other optional additives. Preferably a pre-coated non-woven glass fiber mat is employed to provide the inorganic mineral fibers for the surface reinforcement.

An apparatus for modifying a keratinous surface that has an applicator which includes a motor and an applicator opening which is in fluid communication with a first modification composition. The applicator also includes a sensor and a CPU. The sensor reads the properties of a small portion of the keratinous surface, the readings are transmitted to the CPU, the CPU analyzes the sensor reading of the keratinous surface. The CPU sends a signal to the applicator to treat or not to treat the analyzed surface, and if the CPU sends a signal to the applicator to treat the surface, the motor is activated to move the stylus to the keratinous surface to apply a portion of the first modification composition to the same portion of the keratinous surface that was read by the sensor.

The invention discloses synergistic combinations of surfactants blends and cleaning composition. In certain embodiments a surfactant system is disclosed which includes extended anionic surfactants, linker surfactants, and a multiply charged cation component. This system forms emulsions with, and can remove greasy and oily stains, even those comprised of non-trans fats. In another embodiment anionic surfactants are combined with a solvent, and amine oxide to remove sunscreen stains. The compositions may be used alone, as a pre-spotter or other pre-treatment or as a part of a soft surface or hard surface cleaning composition.

In a sintered body of low temperature cofired ceramic constituting ceramic layers of a multilayer ceramic substrate provided with external conductor films, which is obtained by sintering a non-glass low temperature cofired ceramic material, respective crystalline phases of quartz, alumina, and fresnoite are deposited. The ceramic layers are, because of being in the form of a sintered body of non-glass low temperature cofired ceramic, less likely to fluctuate in composition, and the multilayer ceramic substrate can be thus inexpensively and easily manufactured therefrom. In addition, the ceramic layers have the above-mentioned respective crystalline phases deposited therein, and thus have a high joint strength with the external conductor films, and moreover, the sintered body itself has a high fracture toughness value.

The invention relates to an external traditional Chinese medicine composition preparation. The preparation is characterized in that the preparation comprises the following effective ingredient materials in weight percentage: 0.0001 to 20 percent of a night shade extract and / or a climbing nightshade extract, 0.0001 to 20 percent of one or multiple kinds of a coptis extract, a phellodendron extract, a barberry extract and a mahonia / leaf extract and the balance being auxiliary materials. The invention also discloses another external traditional Chinese medicine composition preparation which is prepared from the following effective ingredient materials: the night shade extract and / or the climbing nightshade extract, one or multiple kinds of the coptis extract, the phellodendron extract, the barberry extract and the mahonia / leaf extract and a scutellaria extract and / or a kuh-seng extract. The external traditional Chinese medicine composition preparation can be prepared into any external preparation form which can be accepted medically. The external traditional Chinese medicine composition preparation has good curative effect, has the effective rate of treating skin diseases of 95 percent through clinical trials, can be used for treating psoriasis, eczema, dermatitis, skin cancer and other symptoms and has strong practicability.

The invention relates to an external pharmaceutical composition preparation with functions of resisting inflammation, reducing swelling and relieving pain, which is characterized in that the preparation is prepared by the following effective component raw materials in weight percent of the whole preparation: 0.01 to 20 percent of escin and / or pharmaceutically acceptable salt thereof, 0.01 to 10 percent of diclofenac or pharmaceutically acceptable salt thereof, and the balance being accessories. The external pharmaceutical composition can be made into any pharmaceutically acceptable external dosage form. The preparation can be used for treating symptoms, such as arthralgia, hyperosteogeny, gout, neuropathic pain, injuries from falls, chronic strain diseases and various closed injuries, and the like, and has strong practicability.

The invention discloses a Chinese patent medicament for treating aplastic anemia. The Chinese patent medicament comprises the following Chinese herbal medicines: prepared rehmannia root, figwort root, dwarf lilyturf tuber, oriental waterplantain rhizome, mulberry, India madder root, gardenia, tree paeony bark, lalang grass rhizome and the like. The Chinese patent medicament contains fewer ingredients according to a formula, is mixed scientifically, does not have toxic or side effect, and has an obvious treatment effect on acute and chronic aplastic anemia. By the treatment with the Chinese patent medicament, the effective rate of the aplastic anemia is over 90 percent, and the cure rate is over 80 percent. The Chinese patent medicament has a good clinical treatment effect on aplastic anemia and has the high safety of clinical administration, and bone marrow transplantation is prevented, so the treatment cost is low.

An inverter for igniting a discharge lamp comprises a transformer, a first switch transistor, a second switch transistor, a first snubber capacitor, a second snubber capacitor, a reset capacitor, and a control circuit. One of the source / drain of the first switch transistor is electrically coupled to the primary side of the transformer. One of the source / drain of the second switch transistor is electrically coupled to the primary side of the transformer. The first snubber capacitor is electrically coupled between the source and the drain of the first switch transistor. The second snubber capacitor is electrically coupled between the source and the drain of the second switch transistor. The reset capacitor is electrically coupled between the other of the source / drain of the first switch transistor and the other of the source / drain of the second switch transistor. The control circuit controls the first switch transistor and the second switch transistor so that the two transistors will not conduct at the same time.

The present invention relates to liquid pharmaceutical formulations for intravitreal injection of an anti-VEGF antibody which does not contain saccharides for use in the treatment of age-related macular degeneration.

The invention relates to an external-use pharmaceutical composition preparation used for resisting inflammation, reducing swelling and relieving pain, which is characterized in that: the raw materials of active ingredients of the prepared medicine and the weight percentages thereof account for the whole preparation are: 0.01 percent to 20 percent of seed extractions of one or a plurality of aesculus wilsonii rehd, horse chestnut, aesculus chinensis bge.var.chekiangensis(Hu et Fang) Fang, European horse-chestnut and Japanese horse chestnut, 0.0001 percent to 20 percent of root extractions of one or a plurality of aconite, aconitum kusnezoffii maxim, aconitum karakolicum, A. sinomontanum, pendulous monkshood root, aconitum vilmorinianum, aconitum austroyunnanense, acomtum hemsleyanum pritz, root of short stalk monkshood radix aconiti brachypodi, scaphoidhelmet monkshood herb, aconitum tanguticum and aconitum nagarum var.lasiandrum, and others are accessories. The invention also discloses another external-use pharmaceutical composition preparation used for resisting inflammation, reducing swelling and relieving pain. The active ingredients of the prepared medicines are seed extractions of one or a plurality of aesculus wilsonii rehd, horse chestnut, aesculus chinensis bge.var.chekiangensis(Hu et Fang)Fang, European horse-chestnut and Japanese horse chestnut, root extractions of one or more than one of aconite, aconitum kusnezoffii maxim, aconitum karakolicum, A. sinomontanum, pendulous monkshood root, aconitum vilmorinianum, aconitum austroyunnanense, acomtum hemsleyanum pritz, root of short stalk monkshood radix aconiti brachypodi, scaphoidhelmet monkshood herb, aconitum tanguticum and aconitum nagarum var.lasiandrum, and one or a plurality of holly extraction, capsicum extraction, corn mint extraction, eucalyptus globules extraction, camphor, borneol and musk.

Various embodiments disclosed relate to absorbent clumping animal litter compositions, and to methods of using and making the same. In some embodiments, the present invention provides an absorbent clumping animal litter composition including an absorbent component and a pumice component.

The invention discloses a Chinese patent medicine for treating globus hysteriocus. The Chinese patent medicine for treating globus hysteriocus comprises the following raw material medicines in parts by weight: 10-100 parts of citron, 10-100 parts of nutgrass galingale rhizome, 100-600 parts of common fennel, 100-500 parts of anise, 10-400 parts of pepper and 10-100 parts of walnut kernel, and also comprises the following auxiliary materials in parts by weight: 100-400 parts of sugar candy, 100-600 parts of white sugar, 100-1,000 parts of black sugar and 300-1,000 parts of balm. The Chinese patent medicine for treating globus hysteriocus has the advantages of less raw material components, scientific matching, no toxic or side effect and synergistic effect between every two medicines; and the globus hysteriocus can be substantially cured. The Chinese patent medicine has an obvious effect on the treatment of the globus hysteriocus; the cure rate of the Chinese patent medicine reaches over 80 percent; and the effectiveness ratio reaches over 96 percent. Through the Chinese patent medicine, the defects of low probability of radical cure, long treatment time and high cost existing in the conventional medicament for treating the globus hysteriocus are overcome.

Tellurium compound nanoparticles, including: an element M1 where M1 is at least one element selected from Cu, Ag, and Au; an element M2 where M2 is at least one element selected from B, Al, Ga, and In; Te; and optionally an element M3 where M3 is at least one element selected from Zn, Cd, and Hg; wherein a crystal structure of the tellurium compound nanoparticles is a hexagonal system, the tellurium compound nanoparticles are of a rod shape and have an average short-axis length of 5.5 nm or less, and when irradiated with light at a wavelength in a range of 350 nm to 1,000 nm, the tellurium compound nanoparticles emit photoluminescence having a wavelength longer than the wavelength of the irradiation light.

Systems and methods include an aromatics complex (ARC), the ARC in fluid communication with a naphtha reforming unit (NREF) and operable to receive a reformate stream produced by the NREF, and the ARC further operable to separate the reformate stream into a gasoline pool stream, an aromatics stream, and an aromatic bottoms stream; and a hydrodearylation unit operable to receive heavy, non-condensed, alkyl-bridged, multi-aromatic compounds from the aromatic bottoms stream, the hydrodearylation unit further operable to hydrogenate and hydrocrack the heavy, non-condensed, alkyl-bridged, multi-aromatic compounds to produce a stream suitable for recycle to the NREF or the reformate stream, where the hydrodearylation unit is further operable to receive hydrogen produced in the NREF.

The invention discloses a Chinese patent medicine for treating a digestive system disease. The Chinese patent medicine for treating the digestive system disease comprises the following crude drugs in parts by weight: 3-40 parts of root of rehmannia, 3-15 parts of dwarf lilyturf root, 3-30 parts of root bark of the peony tree, 3-30 parts of figwort root, 3-30 parts of root of red-rooted salvia and5-30 parts of dry hawthorn. The Chinese patent medicine for treating the digestive system disease is particularly suitable for treating symptoms such as constipation, gastrectasia and the like and has the advantages of definite therapeutic effect, safety, convenience and small side effect. Experience proves that the Chinese patent medicine has an excellent treatment effect on the digestive systemdisease, particularly the constipation, has the functions of invigorating the kidney and nourishing the blood and has an extremely obvious bowel relaxing effect; and the threat of the symptoms such as constipation and the like to the health of people can be obviously reduced.

The present invention relates to a masterbatch comprising colorant particles, a polyol poly(hydroxy fatty acid) ester dispersing agent and a carrier resin. The masterbatch is used for coloring thermoplastic polymer compositions. The present invention also relates to a method for producing said masterbatch, a colored thermoplastic polymer composition comprising said masterbatch and colored thermoplastic products formed of said colored thermoplastic composition.

The invention relates to an externally-used medical compound preparation having the functions of being anti-inflammatory, antipyretic and analgesic. The preparation is characterized in that the preparation is prepared by the following raw materials of active ingredients with the following weight percentages: 0.01 percent to 20 percent of aescin or salts thereof acceptable in pharmacy, 0.01 percent to 10 percent of one or more of ketoprofen, tiaprofenic acid, tiaprofenic salts acceptable in the pharmacy, meloxicam, piroxicam and naproxen, and the rest amount of accessories. The externally-usedmedical composition can be used for preparing any externally-used preparation acceptable in the pharmacy. The preparation of the invention can be used for treating arthrodynia, hyperosteogeny, gout, neuropathic pains, traumatic injuries, chronic eparsalgia, various closed injuries and other diseases, and has strong practicability.